Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment

Sarah E. Thomas; Marieke M.B. Seyger; Josje E. Mangnus; Marisol E. Otero; Antoni H. Gostynski; Marcellus D. Njoo; Paul M. Ossenkoppele; Inge M. Haeck; Judith H.J. Hendricksen-Roelofzen; John E.M. Körver; Sharon R.P. Dodemont; Ron A. Tupker; Maartje A.M. Berends; Lizelotte M.J.T. Weppner-Parren; Romy R.M.C. Keijsers; Annet M. Oostveen; Bas Peters; Roland Mommers; Martijn B.A. van Doorn; Milan Tjioe; Wendelien R. Veldkamp; Astrid L.A. Kuijpers; Marloes M. Kleinpenning; Elke M.G.J. de Jong; Juul M.P.A. van den Reek

doi:10.1007/s40257-024-00868-x

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment

Sarah E. Thomas^*, Marieke M.B. Seyger, Josje E. Mangnus, Marisol E. Otero, Antoni H. Gostynski, Marcellus D. Njoo, Paul M. Ossenkoppele, Inge M. Haeck, Judith H.J. Hendricksen-Roelofzen, John E.M. Körver, Sharon R.P. Dodemont, Ron A. Tupker, Maartje A.M. Berends, Lizelotte M.J.T. Weppner-Parren, Romy R.M.C. Keijsers, Annet M. Oostveen, Bas Peters, Roland Mommers, Martijn B.A. van Doorn, Milan TjioeWendelien R. Veldkamp, Astrid L.A. Kuijpers, Marloes M. Kleinpenning, Elke M.G.J. de Jong, Juul M.P.A. van den Reek

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	685-688
Number of pages	4
Journal	American Journal of Clinical Dermatology
Volume	25
Issue number	4
DOIs	https://doi.org/10.1007/s40257-024-00868-x
Publication status	Published - 27 May 2024

Access to Document

10.1007/s40257-024-00868-x

Cite this

Thomas, S. E., Seyger, M. M. B., Mangnus, J. E., Otero, M. E., Gostynski, A. H., Njoo, M. D., Ossenkoppele, P. M., Haeck, I. M., Hendricksen-Roelofzen, J. H. J., Körver, J. E. M., Dodemont, S. R. P., Tupker, R. A., Berends, M. A. M., Weppner-Parren, L. M. J. T., Keijsers, R. R. M. C., Oostveen, A. M., Peters, B., Mommers, R., van Doorn, M. B. A., ... van den Reek, J. M. P. A. (2024). Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment. American Journal of Clinical Dermatology, 25(4), 685-688. https://doi.org/10.1007/s40257-024-00868-x

@article{9951b528562f4c44a3a4ca3ff6cdbe0c,

title = "Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment",

author = "Thomas, {Sarah E.} and Seyger, {Marieke M.B.} and Mangnus, {Josje E.} and Otero, {Marisol E.} and Gostynski, {Antoni H.} and Njoo, {Marcellus D.} and Ossenkoppele, {Paul M.} and Haeck, {Inge M.} and Hendricksen-Roelofzen, {Judith H.J.} and K{\"o}rver, {John E.M.} and Dodemont, {Sharon R.P.} and Tupker, {Ron A.} and Berends, {Maartje A.M.} and Weppner-Parren, {Lizelotte M.J.T.} and Keijsers, {Romy R.M.C.} and Oostveen, {Annet M.} and Bas Peters and Roland Mommers and {van Doorn}, {Martijn B.A.} and Milan Tjioe and Veldkamp, {Wendelien R.} and Kuijpers, {Astrid L.A.} and Kleinpenning, {Marloes M.} and {de Jong}, {Elke M.G.J.} and {van den Reek}, {Juul M.P.A.}",

year = "2024",

month = may,

day = "27",

doi = "10.1007/s40257-024-00868-x",

language = "English",

volume = "25",

pages = "685--688",

journal = "American Journal of Clinical Dermatology",

issn = "1175-0561",

publisher = "Adis",

number = "4",

}

Thomas, SE, Seyger, MMB, Mangnus, JE, Otero, ME, Gostynski, AH, Njoo, MD, Ossenkoppele, PM, Haeck, IM, Hendricksen-Roelofzen, JHJ, Körver, JEM, Dodemont, SRP, Tupker, RA, Berends, MAM, Weppner-Parren, LMJT, Keijsers, RRMC, Oostveen, AM, Peters, B, Mommers, R, van Doorn, MBA, Tjioe, M, Veldkamp, WR, Kuijpers, ALA, Kleinpenning, MM, de Jong, EMGJ & van den Reek, JMPA 2024, 'Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment', American Journal of Clinical Dermatology, vol. 25, no. 4, pp. 685-688. https://doi.org/10.1007/s40257-024-00868-x

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment. / Thomas, Sarah E.; Seyger, Marieke M.B.; Mangnus, Josje E. et al.
In: American Journal of Clinical Dermatology, Vol. 25, No. 4, 27.05.2024, p. 685-688.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab

T2 - Evaluating Real-World Outcomes in Psoriasis Treatment

AU - Thomas, Sarah E.

AU - Seyger, Marieke M.B.

AU - Mangnus, Josje E.

AU - Otero, Marisol E.

AU - Gostynski, Antoni H.

AU - Njoo, Marcellus D.

AU - Ossenkoppele, Paul M.

AU - Haeck, Inge M.

AU - Hendricksen-Roelofzen, Judith H.J.

AU - Körver, John E.M.

AU - Dodemont, Sharon R.P.

AU - Tupker, Ron A.

AU - Berends, Maartje A.M.

AU - Weppner-Parren, Lizelotte M.J.T.

AU - Keijsers, Romy R.M.C.

AU - Oostveen, Annet M.

AU - Peters, Bas

AU - Mommers, Roland

AU - van Doorn, Martijn B.A.

AU - Tjioe, Milan

AU - Veldkamp, Wendelien R.

AU - Kuijpers, Astrid L.A.

AU - Kleinpenning, Marloes M.

AU - de Jong, Elke M.G.J.

AU - van den Reek, Juul M.P.A.

PY - 2024/5/27

Y1 - 2024/5/27

UR - http://www.scopus.com/inward/record.url?scp=85195493301&partnerID=8YFLogxK

U2 - 10.1007/s40257-024-00868-x

DO - 10.1007/s40257-024-00868-x

M3 - Comment/Letter to the editor

C2 - 38802618

AN - SCOPUS:85195493301

SN - 1175-0561

VL - 25

SP - 685

EP - 688

JO - American Journal of Clinical Dermatology

JF - American Journal of Clinical Dermatology

IS - 4

ER -

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment

Access to Document

Other files and links

Cite this